Two Sigma Advisers
EVH icon

Two Sigma Advisers’s Evolent Health EVH Stock Holding History

Two Sigma Advisers’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-281,900
Closed -$1.13M – 714
2025
Q4 		$1.13M Buy
281,900
+124,500
+79% +$692K ﹤0.01% 1433
2025
Q3 		$1.33M Buy
157,400
+139,400
+774% +$1.35M ﹤0.01% 1321
2025
Q2 		$203K Buy
+18,000
New +$165K ﹤0.01% 2117
2023
Q2 		– Sell
-13,100
Closed -$425K – 2461
2023
Q1 		$425K Sell
13,100
-500
-4% -$15.8K ﹤0.01% 2003
2022
Q4 		$382K Sell
13,600
-174,900
-93% -$5.01M ﹤0.01% 1986
2022
Q3 		$6.77M Sell
188,500
-13,000
-6% -$458K 0.02% 619
2022
Q2 		$6.19M Sell
201,500
-3,000
-1% -$87.4K 0.02% 675
2022
Q1 		$6.61M Buy
204,500
+50,900
+33% +$1.33M 0.02% 683
2021
Q4 		$4.25M Buy
153,600
+81,000
+112% +$2.32M 0.01% 839
2021
Q3 		$2.25M Sell
72,600
-322,600
-82% -$7.74M 0.01% 1186
2021
Q2 		$8.35M Sell
395,200
-69,300
-15% -$1.39M 0.02% 638
2021
Q1 		$9.38M Sell
464,500
-55,300
-11% -$1.05M 0.03% 594
2020
Q4 		$8.33M Sell
519,800
-53,000
-9% -$701K 0.02% 635
2020
Q3 		$7.11M Sell
572,800
-42,200
-7% -$496K 0.02% 638
2020
Q2 		$4.38M Buy
615,000
+113,500
+23% +$760K 0.01% 850
2020
Q1 		$2.72M Buy
501,500
+111,600
+29% +$997K 0.01% 954
2019
Q4 		$3.53M Sell
389,900
-114,000
-23% -$926K 0.01% 977
2019
Q3 		$3.62M Buy
503,900
+16,900
+3% +$121K 0.01% 885
2019
Q2 		$3.87M Buy
487,000
+206,900
+74% +$2.45M 0.01% 932
2019
Q1 		$3.52M Buy
+280,100
New +$4.43M 0.01% 961
2018
Q4 		– Sell
-16,900
Closed -$480K – 2379
2018
Q3 		$480K Sell
16,900
-2,700
-14% -$64.4K ﹤0.01% 1808
2018
Q2 		$413K Buy
+19,600
New +$371K ﹤0.01% 1992
2017
Q1 		– Sell
-60,900
Closed -$901K – 2379
2016
Q4 		$901K Sell
60,900
-7,000
-10% -$138K ﹤0.01% 1613
2016
Q3 		$1.67M Buy
+67,900
New +$1.59M 0.01% 1106

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers's EVH Position: Q1 2026 in Review

Two Sigma Advisers sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 281,900 shares — an estimated $1.13M sold.

Two Sigma Advisers first reported a position in EVH in Q3 2016 and held it in 24 quarters. The position peaked at $9.38M in Q1 2021. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Two Sigma Advisers reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 281,900 Evolent Health shares in Q1 2026, an estimated $1.13M.
  • Two Sigma Advisers first reported a position in Evolent Health in Q3 2016 and held it in 24 quarters.
  • Two Sigma Advisers's Evolent Health position peaked at $9.38M in Q1 2021.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.